HCID 66748212, compound → HCID 66747760, compound

HRID 1405842Notes

Reaction equation

HRID 1405842 reaction equation
[F:1][C:2]([C:5]1[CH:29]=[CH:28][C:8]([O:9][C:10]2[CH:15]=[CH:14][C:13]([C:16]3[C:21]4=[N:22][S:23](=[O:27])(=[O:26])[CH2:24][CH2:25][N:20]4[CH:19]=[CH:18][CH:17]=3)=[CH:12][CH:11]=2)=[CH:7][CH:6]=1)([F:4])[CH3:3]>C1COCC1.CO.[Pt](=O)=O>[F:4][C:2]([C:5]1[CH:6]=[CH:7][C:8]([O:9][C:10]2[CH:11]=[CH:12][C:13]([CH:16]3[C:21]4=[N:22][S:23](=[O:27])(=[O:26])[CH2:24][CH2:25][N:20]4[CH2:19][CH2:18][CH2:17]3)=[CH:14][CH:15]=2)=[CH:28][CH:29]=1)([F:1])[CH3:3]

Participants

5

Procedure

Platinum(IV) oxide (15 mg) was added to a mixture of 9-{4-[4-(1,1-difluoroethyl)phenoxy]phenyl}-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide (300 mg) in THF (dry) (10 mL) and MeOH (10 mL). The mixture was stirred at room temperature under hydrogen overnight. The insoluble solid was removed by filtration through silica gel/Celite pad (eluted with EtOAc) and the filtrate was concentrated in vacuo. The residue was crystallized from THF/IPE to give the title compound (77.7 mg) as colorless crystals.

Workup

  1. customThe insoluble solid was removed by filtration through silica gel/Celite pad (eluted with EtOAc)
  2. concentrationthe filtrate was concentrated in vacuo
  3. customThe residue was crystallized from THF/IPE

Sources & evidence

ORD record
ord-627dfc7526fb47de81580fdeabc3c9b5
Source dataset
uspto-grants-2014_12
Patent number
US08916551B2

Reaction notes

Loading…